BridgeBio Pharma, Inc.

NASDAQ:BBIO

26.83 (USD) • At close September 19, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Omzet 2.168211.121.7454.0911.6411.8261.870.33873.7461.69412.8862.34454.0240.4620.1228.1270013.81926.741000000
Kosten van de omzet 1.8721.8940.5980.5980.5990.6510.6470.7390.71.3481.5511.4540.1090000002.5000000
Brutowinst 0.296209.2261.1473.4931.0421.1751.223-0.40173.0460.34611.3350.8953.9150.4620.1228.1270013.81924.241000000
Brutowinstmarge 0.1370.9910.6570.8540.6350.6430.654-1.1860.9910.2040.880.380.9981110010.907000000
Onderzoek- en ontwikkelingskosten 114.695140.972130.226125.136108.08793.51291.54992.511108.4107.649123.751104.305102.069122.55990.17492.0586.59868.22557.48555.27852.33144.85351.20231.14823.89233.831
Algemene en administratieve kosten 000000000045.4070045.40737.43736.01637.96934.26234.97223.49516.91818.89914.38110.30810.8918.007
Verkoop- en marketingkosten 00000000009.342000000000000000
Verkoop-, algemene en administratieve kosten 58.24964.51147.58335.77736.12231.10831.86231.18836.42643.71354.74946.08445.9745.40737.43736.01637.96934.26234.97223.49516.91818.89914.38110.30810.8918.007
Overige kosten 0.4689.4838.9040.2721.476-0.6014.566.33197.13-7.57528.284-0.6842.4575.7662.9780.009-1.8270.474-0.158-0.026-0.007-0.0070.0050.006-0.716-0.586
Bedrijfskosten 172.944205.483177.809161.185144.209124.62123.411123.699144.826151.362178.5150.389148.039167.966127.611128.066124.567102.48792.45778.77369.24963.75265.58341.45634.78341.838
Bedrijfsresultaat -172.6483.743-177.416-157.692-146.099-126.163-122.188-129.11626.116-151.016-165.614-149.499-94.015-167.504-127.489-119.939-124.567-102.487-78.638-54.532-69.249-63.752-65.583-41.456-34.783-41.838
Bedrijfsresultaat ratio -79.6350.018-101.671-38.546-89.03-69.093-65.341-3820.354-89.148-12.852-63.779-1.74-362.563-1,044.992-14.75800-5.691-2.039000000
Totaal overige inkomsten en kosten netto 97.104-39.90321.024-19.307-2.055-16.569-18.382-11.077-28.675-50.31428.284-0.6842.4575.7662.9780.009-1.8270.474-4.883-6.755-4.737-6.1216.0480.006-0.716-0.586
Inkomen voor belasting -75.544-36.16-170.328-176.999-160.703-142.732-140.57-140.193-2.559-201.33-152.282-161.016-102.074-171.082-135.025-130.167-136.214-104.082-84.151-60.664-74.265-69.436-49.241-42.078-35.702-42.43
Inkomen voor belasting ratio -34.845-0.171-97.609-43.265-97.93-78.166-75.171-414.772-0.035-118.849-11.818-68.693-1.889-370.307-1,106.762-16.01700-6.09-2.269000000
Belastingkosten -2.088-0.94418.358-1.63919.26634.11415.4038.223-61.92445.38115.1345.3024.8837.50141.72-4.071-5.36-10.16317.305-5.56-11.392-11.186-9.691-9.515-9.662-8.853
Nettowinst -73.456-35.216-168.148-176.999-157.899-176.846-155.973-148.41659.365-246.711-147.177-155.935-96.348-163.079-119.981-115.859-121.034-91.85-73.458-59.98-65.895-61.185-38.641-31.401-26.551-34.156
Nettowinstmarge -33.882-0.167-96.36-43.265-96.221-96.849-83.408-439.1010.805-145.638-11.421-66.525-1.783-352.985-983.451-14.25600-5.316-2.243000000
WPA (Winst Per Aandeel) -0.39-0.2-0.96-1.08-0.98-1.16-1.04-10.4-1.69-1.01-1.06-0.66-1.18-1.01-0.98-1.03-0.78-0.62-0.51-0.71-0.51-0.42-0.34-0.29-0.37
Verwaterde WPA -0.39-0.2-0.96-1.08-0.98-1.16-1.04-10.4-1.69-1.01-1.06-0.66-1.18-1.01-0.98-1.03-0.78-0.62-0.51-0.71-0.51-0.42-0.34-0.29-0.37
EBITDA -171.0745.339-169.229-157.692-134.941-117.609-112.889-113.70727.698-156.44-137.148-149.684-91.235-159.979-124.063-119.238-125.46-100.072-81.111-58.411-72.418-66.139-64.28-40.845-35.455-42.397
EBITDA ratio -78.9090.025-96.979-38.546-82.231-64.408-60.368-336.4110.376-92.349-10.643-63.858-1.689-346.275-1,016.91-14.67200-5.87-2.184000000